Sept. 10 Financial Quick Takes: Qiming backs Insilico's B round; plus 10x Genomics, Aprea, Platelet, SGI-DNA, Dermavant, Karuna Labs

By Hongjiang Li, Staff Writer and Val Kennedy, Associate Editor | Sep 10, 2019 | 11:51 PM GMT

Qiming leads Insilico’s $37M B round
Insilico Medicine Inc. (Hong Kong, China) raised $37 million in a series B round led by Qiming Venture Partners. Eight Roads, F-Prime Capital, Lilly Asia Ventures, Sinovation Ventures, Baidu Ventures, Pavilion Capital, BOLD Capital Partners and other undisclosed investors including series A

Read the full 472 word article

How to gain access

Continue reading with a
two-week free trial.